Keyphrases
Epstein-Barr Virus
100%
Virus-specific Cytotoxic T Lymphocytes
100%
Epitope
100%
Nasopharyngeal Carcinoma
100%
Blood Donors
100%
Southern Chinese
100%
Latent Membrane Protein 1 (LMP1)
71%
Healthy Controls
28%
Control Subjects
14%
Western Countries
14%
Virus Proteins
14%
Poor Prognosis
14%
Advanced Stage
14%
Cytotoxic T Lymphocytes
14%
Virus Carriers
14%
Antiviral Immunity
14%
Undifferentiated Nasopharyngeal Carcinoma
14%
Peripheral Blood Mononuclear Cells
14%
ELISpot Assay
14%
Peptide Epitopes
14%
ELISPOT
14%
Newly Diagnosed
14%
Pre-existing Immunity
14%
Chinese Subjects
14%
Medicine and Dentistry
Epstein Barr Virus
100%
Epitope
100%
Cytotoxic T-Cell
100%
Nasopharynx Carcinoma
100%
Blood Donor
100%
Latent Membrane Protein 2
50%
Disease
25%
Enzyme Linked Immunospot Assay
25%
Viral Protein
12%
Immunotherapy
12%
Recurrent Disease
12%
Peripheral Blood Mononuclear Cell
12%
Virus Immunity
12%
Virus Carrier
12%
Pharmacology, Toxicology and Pharmaceutical Science
Epstein-Barr Virus
100%
Nasopharynx Carcinoma
100%
Epitope
100%
Latent Membrane Protein 2
50%
Disease
25%
Viral Protein
12%
Recurrent Disease
12%
Immunotherapy
12%
Virus Carrier
12%
Enzyme-Linked Immunospot Assay
12%
Immunology and Microbiology
Epstein Barr Virus
100%
Cytotoxic T Cell
100%
Epitope
100%
Enzyme-Linked Immunospot Assay
12%
Viral Protein
12%
Immunotherapy
12%
Virus Carrier
12%
Peripheral Blood Mononuclear Cell
12%
Face
12%
ELISPOT
12%
Virus Immunity
12%